<DOC>
	<DOCNO>NCT02731911</DOCNO>
	<brief_summary>This prospective study assess Ozurdex treatment Diabetic Macular Oedema clinical practice .</brief_summary>
	<brief_title>Study OZURDEX® Treatment Diabetic Macular Oedema ( DME ) Australia - The AUSSIEDEX Study</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Pseudophakic phakic schedule cataract operation Macular oedema due DME Previous Ozurdex® treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>